The entire Canadian pot industry is in wait-and-see mode due to the pandemic, both the companies and investors. However, it will not remain that way forever. Is Aphria growing stronger as the lockdowns continue?
Since the beginning of the year, tobacco giant Altria saw its stock price dive. Investors may wonder if the dividend is safe.
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Gun background checks soared in every state last month as people loaded up with firearms at an unprecedented rate. No populous state posted a bigger increase in these checks than Texas.
Can Aurora Cannabis do anything to avoid the same fate as its peers that are circling the drain? Can anything the company does return it to its former glory?
It’s no secret that the cannabis industry has been smoked so far in 2020. Out of this group, Organigram seems to have fared the best. What comes next?
Despite the government aid coming for payroll protection, many small and independent business owners are now worried that they may never recover from the coronavirus-triggered recession.
Constellation Brands reported better than expected fiscal fourth-quarter financial results before the markets opened on Friday.
The U.S. Federal Trade Commission has filed a lawsuit alleging that Altria Group's $12.8 billion investment in e-cigarette maker Juul violated various U.S. antitrust laws.
Canadian pot grower Tilray has released 11 million shares of common stock that had been subject to a lockup period following the company's merger with its largest holder last September.
Investors are scrambling to find yield. Could Altria have just the dividend yield they are looking for? Cigarettes have been considered recession-proof, but this time things may be somewhat different.
Something is moving Tilray stock far higher than other pot stocks. What can account for a 67% one-day jump in the cannabis company's share price?
Stocks like Coca-Cola and PepsiCo were supposed to be about as defensive as they come. Two different analyst reports now suggest that their COVID-19 pandemic damage has been enough.
After brutal sell-offs during the past year, some of the cannabis stocks have bounced back, a relief for many investors. Is Aphria set to be a winner?
CannTrust has been one of the most beat-up marijuana stocks over the past year, but not without reason. Will the cannabis grower finally get its act together, or is this just a race to…
